JonathanAJavitchMD
Psychiatry • New York, NYLieber Professor of Experimental Therapeutics (in Psychiatry) Professor of Pharmacology (in the Center for Molecular Recognition and in Physiology and Cellular Biophysics) Chief, Division of Molecular Therapeutics Director, Lieber Center for Schizophrenia Research and Treatment
Dr. Javitch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1051 Riverside Drive
Molecular Therapeutics, Unit 19
New York, NY 10032Phone+1 646-774-8600Fax+1 775-898-5133- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1986 - 1990
Johns Hopkins University School of MedicineClass of 1986
Certifications & Licensure
NY State Medical License 1987 - 2025- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- Molecular Design of SERTlight: A Fluorescent Serotonin Probe for Neuronal Labeling in the Brain.Wei-Li Lee, Xavier Westergaard, Christopher Hwu, Jennifer Hwu, Tomas Fiala, Clay Lacefield, Umed Boltaev, Adriana M Mendieta, Lisa Lin, Mark S Sonders, Keaon R Brown, ...> ;Journal of the American Chemical Society. 2024 Apr 10
- In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling.Tsai, M., Chen, L., Baumann, M., Canals, M., Lane, J., Shi, L., Javitch, J.> ;ACS Chemical Neuroscience. 2024 Feb 21
- Deciphering downstream receptor signaling.Filizola, M., Javitch, J.> ;Science. 2023 Dec 22
- Join now to see all
Journal Articles
- Arrestin Recruitment to Dopamine D2 Receptor Mediates Locomotion but Not Incentive MotivationJonathan Javitch, MD, Nature
Press Mentions
2022 Leading Research AchievementsJanuary 5th, 2023- CUIMC Update - April 12, 2021April 12th, 2021
- HDRF Honors Taraji P. Henson and Jane Pauley at 14th Virtual Annual HOPE LuncheonNovember 20th, 2020
- Join now to see all
Grant Support
- P3 - Regulation Of Dopamine Transporter FunctionNational Institute On Drug Abuse2011–2012
- Functional Properties Of Protein Segments In Receptors And TransportersNational Institute On Drug Abuse2009–2012
- Training In Schizophrenia And Psychotic Disorders: From Animal Models To PatientsNational Institute Of Mental Health2010–2011
- Molecular Mechanisms Of Bacterial Homologs Of Neurotransmitter:Sodium SymportersNational Institute On Drug Abuse2009–2011
- Structure And Function Of Dopamine ReceptorsNational Institute Of Mental Health2008–2011
- Molecular Determinants For The Action Of PsychostimulantsNational Institute On Drug Abuse2007–2011
- Schizophrenia Research FellowshipNational Institute Of Mental Health2007–2009
- Structure And Function Of The Dopamine TransporterNational Institute On Drug Abuse2005–2009
- Dopamine Transporter: Substrate &Cocaine Binding SitesNational Institute On Drug Abuse2006–2007
- Archaeal &Bacterial Homologs Of Dopamine TransporterNational Institute On Drug Abuse2003–2007
- Structure Of The Dopamine D2-Like Receptor Binding SitesNational Institute Of Mental Health2006
- Molecular Recognition Of Antipsychotic Drugs And CocaineNational Institute Of Mental Health1997–2006
- 2004 &2006 Membrane Transport Proteins Gordon ConferenceNational Institute Of Mental Health2004–2005
- Dopamine Transporter: Substrate &Cocaine Binding SitesNational Institute On Drug Abuse2003–2005
- Structure Of The Dopamine D2-Like Receptor Binding SitesNational Institute Of Mental Health2002–2005
- Archaeal &Bacterial Homologs Of Dopamine TransporterNational Institute On Drug Abuse2001–2002
- Structure/Function Of The Human Dopamine TransporterNational Institute On Drug Abuse1999–2002
- Dopamine Transporter--Substrate &Cocaine Binding SitesNational Institute On Drug Abuse1998–2002
- Structure Of The Dopamine D2 &D4 Receptor Binding SitesNational Institute Of Mental Health1995–2001
- Molecular Recognition Of Antipsychotic DrugsNational Institute Of Mental Health1995–1996
- Molecular Recognition Of Antipsychotic DrugsNational Institute Of Mental Health1992–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
